ssris

  1. rvallee

    Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders A Randomized Clinical Trial, 2024, Mete et al

    Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders A Randomized Clinical Trial https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2798510 Abstract Importance: Anxiety disorders are common, highly distressing, and impairing...
  2. rvallee

    Beyond “Psychotropic”: Repurposing Psychiatric Drugs for COVID-19, Alzheimer’s Disease, and Cancer, 2023, Santosh et al

    Beyond “Psychotropic”: Repurposing Psychiatric Drugs for COVID-19, Alzheimer’s Disease, and Cancer https://www.psychiatrist.com/jcp/beyond-psychotropic-repurposing-psychiatric-drugs-covid-19-alzheimer-disease-cancer/ Importance: “Psychotropic” drugs have widespread reach and impact throughout...
  3. SNT Gatchaman

    Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19, 2024, Sidky et al.

    Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19 Hythem Sidky; Kristen A. Hansen; Andrew T. Girvin; Nathan Hotaling; Sam G. Michael; Ken Gersing; David K. Sahner BACKGROUND Post-acute sequelae of COVID-19 (PASC) produce...
  4. rvallee

    Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases, 2023, Brasanac et al

    Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases An Umbrella Systematic Review and Meta-Analysis JAMA Psychiatry: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2809163 Key Points Question What is the evidence for use of...
  5. SNT Gatchaman

    Treatment of 95 post-Covid patients with SSRIs, 2023, Rus et al.

    Treatment of 95 post-Covid patients with SSRIs Rus, Carla P.; de Vries, Bert E. K.; de Vries, Ingmar E. J.; Nutma, Idelette; Kooij, J. J. Sandra After Covid-19 infection, 12.5% develops post-Covid-syndrome (PCS). Symptoms indicate numerous affected organ systems. After a year, chronic fatigue...
  6. rvallee

    Findings From a Survey of 530 British Antidepressant Users

    Antidepressant users report urgent need for services to assist with withdrawal. https://www.psychologytoday.com/gb/blog/psychiatry-through-the-looking-glass/202309/findings-from-a-survey-of-530-british In a survey of British antidepressant users, 70% experienced "severe withdrawal effects"...
  7. cassava7

    The serotonin theory of depression: a systematic umbrella review of the evidence, Moncrieff et al, 2022

    Joanna Moncrieff, Ruth E. Cooper, Tom Stockmann, Simone Amendola, Michael P. Hengartner & Mark A. Horowitz The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or...
  8. leokitten

    Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial. Lenze et al. JAMA (2020)

    An SSRI to treat early COVID, supposedly SSRIs can inhibit SARS-CoV-2 and also potentially have anti-inflammatory and immunoregulatory properties. I think also earlier this year there was an observational study showing patients taking SSRIs had lower risk of severe COVID and death (I think a...
  9. svetoslav80

    Venlafaxine (Velaxin, Effexor)

    I've been taking venlafaxine XR for 6 days, and today I increased the dose to 225 mg / day as prescribed. It seems to work well for depression and anxiety, however I'm getting tired much faster than usual. Before I was able to concentrate on some task for an hour or two , and after some break -...
Back
Top Bottom